Despite the sweeping scope of the ban covering various types of drug molecules, biopharma business development teams can ...

Merck & Co. and Moderna have shared highly anticipated phase 3 data on their cancer vaccine, revealing a primary endpoint hit ...

Georgiamune, an immunology-focused biotech out of Maryland, has licensed a preclinical cancer drug candidate to Menarini ...

Celltrion has licensed a preclinical antibody aimed at autoimmune conditions from Maryland-based biotech Kaigene in a deal ...

Quest Diagnostics is the latest life sciences company to fall victim to a cyberattack, with the company believing patient ...

Researchers are exploring a revolutionary way to predict a patient's response to immunotherapies by creating a tumor “avatar” ...

| GSK may have cemented its hepatitis B credentials with Tuesday’s landmark FDA nod for its “functional cure” bepirovirsen, ...

Roche has dived into the data behind its filing for FDA approval of fenebrutinib in multiple sclerosis (MS), unpacking the ...

Japan's Astellas Pharma has tapped Boston computational discovery company AI Proteins in a drug discovery deal potentially ...

The FDA's Center for Biologics Evaluation and Research (CBER) is recovering from the most turbulent period in its recent ...

Reverse mergers have returned with a bang. More biotechs have taken this back door to the public markets so far in 2026 than ...

Hologic is acquiring precision oncology company Reveal Genomics. | Hologic is acquiring precision oncology company Reveal ...